Buzzing Politics
  • News
  • Privacy Policy
  • Terms of Use
  • Disclaimer
Select Page

iRhythm Tech’s Stock Selloff Went Too Far After Preliminary Update: Analyst

by Vandana Singh | Jan 14, 2026 | General

On Monday, iRhythm Technologies Inc. (NASDAQ:IRTC) reported preliminary fourth quarter operational highlights. The digital health company anticipates full-year 2025 revenue to exceed the high end of the previously stated guidance range of $740 million provided in...

Why This Top Analyst Sees Meta Platforms Stock Surging 77%

by Anusuya Lahiri | Jan 14, 2026 | General

A wave of strategic announcements has sharpened Wall Street’s focus on Meta Platforms Inc. (NASDAQ:META) as analysts assess how the company is positioning itself for long-term AI growth. Rosenblatt Stays Bullish On Meta’s Strategy Rosenblatt analyst Barton...

Amazon’s Cloud Growth Tied To AI Advances, Analyst Says

by Henry Khederian | Jan 14, 2026 | General

Amazon.com Inc (NASDAQ:AMZN) shares are down on Wednesday. The stock is pulling back following a recent bullish analyst report that highlights potential growth in Amazon Web Services (AWS) driven by advancements in artificial intelligence. Wednesday’s move lower...

Crude Oil Gains Over 1%; US Retail Sales Rise 0.6% In November

by Avi Kapoor | Jan 14, 2026 | General

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 350 points on Wednesday. The Dow traded down 0.55% to 48,922.97 while the NASDAQ declined 1.58% to 23,335.70. The S&P 500 also fell, dropping, 1.06% to 6,889.76. Check...

Apollo Leads $3.5 Billion AI Infrastructure Financing To Power Elon Musk’s xAI

by Caroline Ryan | Jan 14, 2026 | General

Apollo Global Management (NYSE:APO) has led a $3.5 billion financing package for Valor Compute Infrastructure (VCI), a fund run by Valor Equity Partners. This money will help fund a $5.4 billion acquisition and lease of data-center infrastructure, including Nvidia...

Amgen Reports MariTide Weight Loss Holds Up With Fewer Doses

by Vandana Singh | Jan 14, 2026 | General

At a J.P. Morgan Healthcare Conference on Monday, Amgen Inc.(NASDAQ:AMGN) CEO Robert Bradway shared findings from part 2 of the Phase 2 Study of MariTide, its investigational obesity treatment. • Amgen stock is showing positive momentum. What’s the outlook for AMGN...
« Older Entries
Next Entries »

Recent Posts

  • If You Invested $100 In Barrick Mining Stock 5 Years Ago, You Would Have This Much Today
  • Trump’s Davos Energy Pitch Fuels Traditional Energy, Nuclear, Pressures Clean Energy ETFs
  • PayPal (PYPL) Stock Jumps As Trump Shelves Tariff Threat
  • Here’s How Much You Would Have Made Owning Marsh Stock In The Last 15 Years
  • Options Corner: Greenland-Related Fears Present A Contrarian Gift For Bank Of America Speculators

Recent Comments

    Archives

    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019

    Categories

    • Breaking
    • Business
    • Daily
    • General
    • Markets
    • News
    • Reports
    • Technology

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • News
    • Privacy Policy
    • Terms of Use
    • Disclaimer
    Copyright 2019 Karmaholic Media LLC. All Rights Reserved.